SUBSCRIBERS
Long-term view allows Temasek to be patient with poor performers
Published Tue, Jul 9, 2019 · 09:50 PM
Singapore
TEMASEK Holdings can stay the course with its poor performers because it invests for the long term.
The point was made at Temasek's annual review on Tuesday, after shares of German life science giant Bayer had fallen by 39 per cent since April 2018, when Temasek put an additional three billion euros (S$4.8 billion) into the company.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Barclays prices mortgage-backed notes in deal with GoldenTree
ExxonMobil to take 18 to 24 months to hit full stride with Pioneer purchase
Luminar to cut nearly 20% jobs as part of restructuring
TD risks an earnings hit from US laundering probe, analysts say
Everything Apple plans to show at May 7 ‘let loose’ iPad event
BNP weighing up to 150 job cuts in Geneva to slash costs